The monocyte chemoattractant protein-1 is a potent cell signaling molecule involved in the activation of mononuclear phagocytes, but its role in the pathogenesis of HIV-associated dementia (HAD) has been unclear. In the September 30 early edition of
Gonzalez et al. studied cohorts of HIV-1 infected adults and children and observed that homozygosity for the MCP-1 –2578G allele was associated with a 50% reduction in the risk of acquiring HIV-1. But, once HIV-1 infection was established, the same MCP-1 genotype was associated with accelerated disease progression and a 4.5-fold increased risk of developing HAD. In addition, they showed that at the molecular level the mutant allele...